Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenu archivé le 2024-06-18

Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling

Description du projet


Virtual Physiological Human

The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union in excess of €56 billion per annum. Current therapies are inadequate and we do not have sufficient tools to predict disease progression or response to current or future therapies. Our consortium, Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM), brings together the exisiting clinical consortia (EvA FP7, U-BIOPRED IMI and BTS Severe Asthma), and expertise in physiology, radiology, image analysis, bioengineering, data harmonization, data security and ethics, computational modeling and systems biology. We shall develop an integrated multi-scale model building upon existing models. This airway model will be comprised of an integrated 'micro-scale' and 'macro-scale' airway model informed and validated by 'omic data and ex vivo models at the genome-transcriptome-cell-tissue scale and by CT and functional MRI imaging coupled to detailed physiology at the tissue-organ scale utilising Europe's largest airway disease cohort. Validation will be undertaken cross-sectionally, following interventions and after longitudinal follow-up to incorporate both spatial and temporal dimensions. AirPROM has a comprehensive data management platform and a well-developed ethico-legal framework. Critically, AirPROM has an extensive exploitation plan, involving at its inception and throughout its evolution those that will 'develop' and 'use' the technologies emerging from this project. AirPROM therefore will bridge the critical gaps in our clinical management of airways disease, by providing validated models to predict disease progression and response to treatment and the platform to translate these patient-specific tools, so as to pave the way to improved, personalised management of airways disease.

Champ scientifique

Programme(s)

Thème(s)

Appel à propositions

FP7-ICT-2009-6
Voir d’autres projets de cet appel

Régime de financement

CP - Collaborative project (generic)

Coordinateur

UNIVERSITY OF LEICESTER
Contribution de l’UE
€ 2 120 019,00
Adresse
UNIVERSITY ROAD
LE1 7RH Leicester
Royaume-Uni

Voir sur la carte
Région
East Midlands (England) Leicestershire, Rutland and Northamptonshire Leicester
Type d’activité
Higher or Secondary Education Establishments
Contact administratif
Marie Adams (Ms.)
Liens
Coût total
Aucune donnée

Participants (39)

Partager cette page

Télécharger

Dernière mise à jour: 2 Août 2019

Mon livret

Permalink: https://cordis.europa.eu/project/id/270194/fr

European Union, 2024